As of 3:15pm ET
| +3.46 / +8.01%|
The 3 analysts offering 12-month price forecasts for Madrigal Pharmaceuticals Inc have a median target of 63.00, with a high estimate of 65.00 and a low estimate of 62.00. The median estimate represents a +35.08% increase from the last price of 46.64.
The current consensus among 3 polled investment analysts is to Buy stock in Madrigal Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.